Cardiovascular risk factors identified in adult patients receiving Primary Health Care: an integrative review
DOI:
https://doi.org/10.21527/2176-7114.2026.51.16430Keywords:
risk factors, cardiovascular diseases, adult, primary health care, healthcare professionalsAbstract
Objective: To provide a synthesis based on current scientific evidence regarding the factors that trigger cardiovascular diseases and can be identified by healthcare professionals during the care of the adult population in Primary Health Care. Methods: This study consists of an Integrative Literature Review of publications from 2019 to 2024, conducted using BVS, Scopus, Web of Science (WoS), and PubMed databases. The guiding research question was: “What information on the identification of cardiovascular risk factors is necessary to support healthcare professionals in primary care during the delivery of care to adult patients?”. Results: Rayyan software was used to assist in bibliographic management, resulting in a total of 26 articles included in the study. To facilitate data comparison, enhance the understanding of relationships among risk factors, and optimize the analysis, similarity analysis was performed using IRaMuTeQ software. The main risk factors identified were hypertension, diabetes, dyslipidemia, smoking, physical inactivity, obesity, gender, age, and depression. Conclusion: Although cardiovascular disease risk factors are relatively easy to identify, their diagnosis in primary care is often delayed, increasing the risk of adverse events and compromising overall health outcomes. Early detection enables more effective preventive actions and a reduction in morbidity and mortality. Therefore, improving the technical and scientific knowledge of PHC professionals is essential, aligning with the objective of this study to compile evidence on the factors that trigger CVD in the adult population.
References
1. Organização Pan-Americana da Saúde. Organização Mundial da Saúde. Região das Américas. Doenças cardiovasculares [Internet]. [citado 2024 jun 29]. Disponível em: https://www.paho.org/pt/topicos/doencas-cardiovasculares
2. Crump C, Sundquist J, Sundquist K. Risk of hypertension into adulthood in persons born prematurely: a national cohort study. Eur Heart J. 2020;41(16):1542–50. doi:10.1093/eurheartj/ehz904
3. World Health Organization (WHO). Global report on smoking and health [Internet]. 2023 [citado 2024 ago 13]. Disponível em: www.who.int
4. Brasil. Ministério da Saúde. Use o coração para vencer as doenças cardiovasculares [Internet]. Brasília: Ministério da Saúde; 2021 [citado 2024 maio 15]. Disponível em: https://bvsms.saude.gov.br/use-o-coracao-para-vencer-as-doencas-cardiovasculares-29-9-dia-mundial-do-coracao/
5. Bechraki, L. et al. Relationship between obesity index and cardiovascular risk in primary care patients on Crete, Greece: a data driven sub-analysis, Grécia, Ann Ig, v. 34, n. 3, p. 259- 265, ago. 2022. doi: 10.7416/ai.2021.2464.
6. Armas-Padrón AM, Sicilia-Sosvilla M, Rodríguez-Bello S, López-Carmona MD, Ruiz-Esteban P, Hernández D. Abnormal ankle-brachial index, cardiovascular risk factors and healthy lifestyle factors in hypertensive patients: prospective cohort study from a primary care urban population. BMC Primary Care. 2022;23(1):232. doi: https://doi.org/10.1186/s12875-022-01837-1
7. Precoma DB, Oliveira, GMM, Simão AF, Dutra OP, Coelho OR, Izar MCO, et al. Diretriz de prevenção cardiovascular atualizada da Sociedade Brasileira de Cardiologia. Arquivos brasileiros de cardiologia. 2019; 113:787-891.
8. Hanif AAM, Hasan M, Khan MSA, Hossain MM, Shamim AA, Hossaine M, et al. Ten- years cardiovascular risk among Bangladeshi population using non-laboratory-based risk chart of the World Health Organization: Findings from a nationally representative survey. PloS one. 2021;16(5):e0251967. DOI: https://doi.org/10.1371/journal.pone.0251967
9. Flood D, Edwards EW, Giovannini D, Ridley E, Rosende A, Herman WH, Jaffe MG, DiPette DJ. Integrating hypertension and diabetes management in primary health care settings: HEARTS as a tool. Rev Panam Salud Publica. 2022 Sep 2;46:e150. doi: 10.26633/RPSP.2022.150.
10. Dantas HL de L, Costa CRB, Costa L de MC, Lúcio IML, Comassetto I. Como elaborar uma revisão integrativa: sistematização do método científico. Revista Recien. 2022;12(37):334-45. doi: 10.24276/rrecien2022.12.37.334-345
11. Souza MT, Silva MD, Carvalho R. Revisão integrativa: o que é e como fazer. Einstein. 2010;8(1):102-6. doi: 10.1590/s1679-45082010rw1134
12. Marchand P, Ratinaud, P. L’analyse de similitude appliquée aux corpus textuels: les primaires socialistes pour l’élection présidentielle française. JADT. 2012;2012:687-699.
13. Camargo BV, Justo AM. IRAMUTEQ: um software gratuito para análise de dados textuais. Temas em psicologia. 2013;21(2):513-518. doi:10.9788/TP2013.2-16
14. Andal-Saniano AC, Espallardo NM, Lardizabal-Bunyi, JE, Aguirre-Pedro D, Medina DM, Laude TM P, et al. Diagnosis and management of Dyslipidemia in family practice. The Filipino Family Physician. 2021;59(2):215-233.
15. Rachamin Y, Grischott T, Rosemann T, Meyer MR. Inferior control of low-density lipoprotein cholesterol in women is the primary sex difference in modifiable cardiovascular risk: A large-scale, cross-sectional study in primary care. Atherosclerosis. 2021;324:141-147. doi: https://doi.org/10.1016/j.atherosclerosis.2021.02.024
16. Doble A, Bescos R, Witton R, Shivji S, Ayres R, Brookes Z. A Case-Finding Protocol for High Cardiovascular Risk in a Primary Care Dental School-Model with Integrated Care. Int J Environ Res Public Health. 2023 Mar 11;20(6):4959. doi: https://doi.org/10.3390/ijerph20064959
17. Reynolds HR, Bairey Merz CN, Berry C, Samuel R, Saw J, Smilowitz NR, et al. Coronary arterial function and disease in women with no obstructive coronary arteries. Circulation research. 2022;130(4):529-551. doi: https://doi.org/10.1161/CIRCRESAHA.121.319892
18. Calling S, Johansson SE, Wolff M, Sundquist J, Sundquist K. Total cholesterol/HDL-C ratio versus non-HDL-C as predictors for ischemic heart disease: A 17-year follow-up study of women in southern Sweden. BMC cardiovascular disorders. 2021;21:1-9. doi: https://doi.org/10.1186/s12872-021-01971-1
19. Wilson PW, Jacobson TA, Martin SS, Jackson EJ, Le NA, Davidson MH, et al. Lipid measurements in the management of cardiovascular diseases: practical recommendations a scientific statement from the national lipid association writing group. Journal of clinical lipidology. 2021;15(5):629-648. doi: https://doi.org/10.1016/j.jacl.2021.09.046
20. Instituto Brasileiro de Geografia e Estatística, Diretoria de Pesquisas, & Coordenação de Trabalho e Rendimento. Pesquisa Nacional de Saúde: 2019: ciclos de vida-Brasil. 2021;139.
21. Motta ACSV, Bousquet-Santos K, Motoki IHL, Andrade JMDL. Prevalência de saúde cardiovascular ideal na população adulta brasileira-Pesquisa Nacional de Saúde 2019. Epidemiologia e Serviços de Saúde. 2023;32:e2022669. doi: https://doi.org/10.1590/S2237-96222023000300006
22. Ferreira APDS, Szwarcwald CL, Damacena GN, Souza PRBD. Increasing trends in obesity prevalence from 2013 to 2019 and associated factors in Brazil. Rev Bras Epidemiol. 2022;24(suppl 2):e210009. doi:10.1590/1980-549720210009.supl.2
23. Brasil. Ministério da Saúde. Sobrepeso e Obesidade como problema de saúde pública. Governo Federal do Brasil 2022. Acesso em 07 de julho 2024. Disponível em: https://www.gov.br/saude/pt-br/assuntos/saude-brasil/eu-quero-ter-peso- saudavel/noticias/2022/sobrepeso-e-obesidade-como-problemas-de-saude-publica.
24. Jayedi A, Soltani S, Zargar MS, Khan TA, Shab-Bidar S. Central fatness and risk of all cause mortality: systematic review and dose-response meta-analysis of 72 prospective cohort studies. Bmj. 2020;370. doi: doi: https://doi.org/10.1136/bmj.m3324
25. Touloumi G, Karakosta A, Kalpourtzi N, Gavana M, Vantarakis A, Kantzanou M. et al. High prevalence of cardiovascular risk factors in adults living in Greece: the EMENO National Health Examination Survey. BMC Public Health. 2020; 20:1-10. doi: https://doi.org/10.1186/s12889-020-09757-4
26. World Health Organization (WHO). (2024). Global Report on Smoking and Health. WHO. Acesso: 20 de julho de 2024. Disponível em: Tobacco (who.int)
27. Kamieńska A, Chlabicz S. Arterial stiffness a cardiovascular risk factor to assess among primary care patients. Folia Medica Cracoviensia. 2022;62(2):109-120. doi: 10.24425/fmc.2022.141704
28. Magalhães MIS, de Macedo AGM, Alves AP da P, de Araújo CFB, Queiroga CG, Franco CMM de A, et al. Impacto das doenças cardiovasculares na progressão da doença renal crônica. Rev. Foco. 2023;16(7):e2149. doi: https://doi.org/10.54751/revistafoco.v16n7-046
29. Ortiz A, Wanner C, Gansevoort R, Council E. Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association. European journal of preventive cardiology. 2022;29(17):2211-2215. doi: https://doi.org/10.1093/eurjpc/zwac186
30. Matsushita K, Kaptoge S, Hageman SH, Sang Y, Ballew SH, Grams ME, et al. Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP. European journal of preventive cardiology. 2023;30(1):8-16. doi: https://doi.org/10.1093/eurjpc/zwac176
31. De Assis LV, Dornelas AS, Fernandes C, Macêdo CVA, do Prado JPV, Chiriano M, et al. Influência de fatores emocionais no desenvolvimento de doenças cardiovasculares: uma revisão narrativa. Rev Eletrônica Acervo Saúde. 2021;13(2):e6457. doi:10.25248/reas.e6457.2021
32. Szőllősi GJ, Csenteri O, Jancsó Z, Vajer P, Kardos L, Andréka P. Association between alcohol consumption and cardiovascular risk based on data from the three generations for health program in Hungary. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research. 2023;29:e940327-1. doi: 10.12659/MSM.940327
33. Rantanen AT, Korkeila JJA, Kautiainen, H, Korhonen PE. Poor or fair self-rated health is associated with depressive symptoms and impaired perceived physical health: a cross-sectional study in a primary care population at risk for type 2 diabetes and cardiovascular disease. European Journal of General Practice, 2019;25(3):143-148. doi: https://doi.org/10.1080/13814788.2019.1635114
34. Di Giacomo D, Ranieri J, Guerra F, Cilli E, Sciarra L, Romano S. Cardiovascular risk and biopsychosocial interplay: Association among hypertension, anxiety, and emotional dysregulation observational study in primary care setting for efficient self‐care. Clinical Cardiology, 2024;47(1):e24152. doi: https://doi.org/10.25248/reas.e6457.2021
35. El Baou C, Desai R, Cooper C, Marchant NL, Pilling S, Richards M, et al. Psychological therapies for depression and cardiovascular risk: evidence from national healthcare records in England. European Heart Journal. 2023;44(18);1650-1662. doi: https://doi.org/10.1093/eurheartj/ehad188
36. Crump C, Groves A, Sundquist J, Sundquist K. Association of Preterm Birth With Long- term Risk of Heart Failure Into Adulthood. JAMA Pediatr. 2021;175(7):689–697. doi:10.1001/jamapediatrics.2021.0131
37. Venetkoski M, Joensuu J, Gissler M, Ylikorkala O, Mikkola TS, Savolainen-Peltonen H. Pre-eclampsia and cardiovascular risk: a long-term nationwide cohort study on over 120 000 Finnish women. BMJ open. 2020;12(12):e064736. doi: https://doi.org/10.1136/bmjopen- 2022-064736
38. Salgado ALC, Moreira JG, Dias MEV, Carvalho ALN, Viana ECC. Pré-eclâmpsia e risco cardiovascular de longo prazo em mulheres: manifestações clínicas e abordagens de tratamento. Rev Eletrônica Acervo Saúde. 2024;10(7):525–34. doi:10.51891/rease.v10i7.14775
39. Santana GQ, Reis IFL, Reis LFG, Rodrigues MJA, Silveira NLLF, Santana TMGQ. Relação do índice tornozelo-braquial como preditor de risco cardiovascular em pacientes submetidos a cateterismo cardíaco de uma cidade de Minas Gerais. REAS. 2021;13(10):e8977. doi: https://doi.org/10.25248/reas.e8977.2021
40. Oliveira AC, Cunha PMGM, Vitorino PVO, Souza ALL, Deus GD, Feitosa A, et al. Envelhecimento Vascular e Rigidez Arterial. Arq. Bras. Cardiol. 2022;119(4):604-15. doi: https://doi.org/10.36660/abc.20210708
41. Strongman H, Herrett E, Jackson R, Sweeting M, Lyon AR, Stanway S, et al. Cancer history as a predictor in cardiovascular risk scores: a primary care cohort study. British Journal of General Practice. 2023;73(726):e34-e42. doi: https://doi.org/10.3399/BJGP.2022.0088
42. Lopes NLS, Maués TD, de Melo RA, do Nascimento RG, da Costa CK, Sarges EDSNF, et al. Achados cardiopulmonares e funcionais em idosos com doença pulmonar obstrutiva crônica. Revista CPAQV, 2020;12(2):2. doi: https://doi.org/10.36692/cpaqv-v12n2-20
43. Gomes EB, Moreira TMM, Pereira HCV, Sales IB, Lima FET, Freitas CHA de, et al. Fatores de risco cardiovascular em adultos jovens de um município do Nordeste brasileiro. Rev Bras Enferm [Internet]. 2012Jul;65(4):594–600. Available from: https://doi.org/10.1590/S0034-71672012000400007
44. Dias G dos S, Costa MCB, Ferreira T das N, Fernandes V dos S, Silva LL da, Júnior LMS, et al. Fatores de risco associados à Hipertensão Arterial entre adultos no Brasil: uma revisão integrativa. Braz J Dev. 2021 Jan;7(1):962–77. doi:10.34117/bjdv7n1-064
45. Hippisley-Cox J, Coupland CAC, Bafadhel M, Russell REK, SheikhA, Brindle P, et al. Development and validation of a new algorithm for improved cardiovascular risk prediction. Nature medicine. 2024;30(5):1440–1447. doi: https://doi.org/10.1038/s41591- 024-02905-y
46. Abraham G, Rutten-Jacobs L, Inouye M. Risk Prediction Using Polygenic Risk Scores for Prevention of Stroke and Other Cardiovascular Diseases. Stroke. 2021;52(9):2983-2991. doi:10.1161/STROKEAHA.120.032619
47. Ordunez P, Tajer C, Gaziano T, Rodriguez YA, Rosende A, Jaffe MG. The HEARTS app: a clinical tool for cardiovascular risk and hypertension management in primary health care. Revista Panamericana de Salud Pública. 2023;46:e12. doi: https://doi.org/10.26633/RPSP.2022.12
48. Sun L, Pennells L, Kaptoge S, Nelson CP, Ritchie SC, Abraham G, et al. Polygenic risk scores in cardiovascular risk prediction: A cohort study and modelling analyses. PLoS medicine. 2021;18(1):e1003498. doi: https://doi.org/10.1371/journal.pmed.1003498
49. Sofogianni A, Stalikas N, Antza C, Tziomalos K. Cardiovascular Risk Prediction Models and Scores in the Era of Personalized Medicine. J Pers Med. 2022;12(7):1180. doi: https://doi.org/10.3390/jpm12071180
50. Barroso WKS, Rodrigues CIS, Bortolotto LA, Mota-Gomes MA, Brandão AA, Feitosa ADM, et al. Diretrizes brasileiras de hipertensão arterial – 2020. Arq Bras Cardiol. 2021;116:516-658.
51. Abril-López PA, Vega-Falcón V, Pimienta-Concepción I, Molina-Gaibor ÁA, Ochoa- Andrade MJ. Risk of cardiovascular disease according to the Framingham score in patients with high blood pressure from Píllaro, Ecuador. 2017-2018. rev.fac.med. 2021;69(3):e208. doi: https://doi.org/10.15446/revfacmed.v69n3.83646
52. Sebold FJG, Schuelter‐Trevisol F, Nakashima L, Della JAP, Pereira MR, Trevisol DJ. Alterações eletrocardiográficas na população adulta de cidade do sul do Brasil: estudo populacional. Revista Portuguesa de Cardiologia. 2015;34(12):745-751. doi: https://doi.org/10.1016/j.repc.2015.07.006
53. Tin YY, Chan LP, Sung JG, Leung SY, Hui EMT, Leung MKW. Prevalence of major electrocardiographic abnormalities in patients with hypertension in a primary care clinic in Hong Kong. BMC Cardiovascular Disorders. 2022;22(1):225. doi: https://doi.org/10.1186/s12872-022-02662-1
54. Marques SP, Lima MJ, Neves PM, Espiga de Macedo M. Prevalence of cardiovascular risk factors and other comorbidities in patients with hypertension in Portuguese primary health care populations: The PRECISE study. Revista Portuguesa de Cardiologia. 2019;38(6):427-437. doi: https://doi.org/10.1016/j.repce.2018.09.012
55. Silva EFD, Cotta RMM, Mendonça ÉT, Oliveira DMD, Cardoso SA, Colodette RM, et al. Optimal Cutoff of the TG/HDL-c ratio for Cardiovascular Risk in Hypertensive and Diabetic Patients Monitored by Primary Health Care in a city in Minas Gerais. International Journal of Cardiovascular Sciences. 2021; 34(5Supl1):55-65. doi: https://doi.org/10.36660/ijcs.20200290
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Ana Ricelly Pereira de Oliveira, Daniele Mesquita Batista, Adjanny Estela Santos de Souza
This work is licensed under a Creative Commons Attribution 4.0 International License.
By publishing in Revista Contexto & Saúde, authors agree to the following terms:
The works are licensed under the Creative Commons Atribuição 4.0 Internacional (CC BY 4.0) license, which allows:
Share — to copy and redistribute the material in any medium or format;
Adapt — to remix, transform, and build upon the material for any purpose, including commercial.
These permissions are irrevocable, provided that the following terms are respected:
Attribution — authors must be properly credited, with a link to the license and indication of any changes made.
No additional restrictions — no legal or technological measures may be applied that restrict the use permitted by the license.
Notes:
The license does not apply to elements in the public domain or covered by legal exceptions.
The license does not grant all rights necessary for specific uses (e.g., image rights, privacy, or moral rights).
The journal is not responsible for opinions expressed in the articles, which are the sole responsibility of the authors. The Editor, with the support of the Editorial Board, reserves the right to suggest or request modifications when necessary.
Only original scientific articles presenting research results of interest that have not been published or simultaneously submitted to another journal with the same objective will be accepted.
Mentions of trademarks or specific products are intended solely for identification purposes, without any promotional association by the authors or the journal.
License Agreement (for articles published from September 2025): Authors retain copyright over their article and grant Revista Contexto & Saúde the right of first publication.
